Please Wait
Applying Filters...
menu
    • menu
    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    An Enquiry

    Menu

    Entacapone orion

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 222Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Alembic Pharma Receives USFDA Approval For Generic Parkinson's
    Alembic Pharma Receives USFDA Approval For Generic Parkinson's

    07 Feb 2026

    // INDPHARMAPOST

    https://www.indianpharmapost.com/drug-approval/alembic-pharmaceuticals-gets-usfda-nod-for-generic-parkinsons-disease-treatment-tablets-19054

    INDPHARMAPOST
    07 Feb 2026
    Share Share
    Alembic Pharma Receives USFDA Approval For Generic Parkinson's
    Alembic Pharma Receives USFDA Approval For Generic Parkinson's

    06 Feb 2026

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/alembic-pharmaceuticals-gets-usfda-nod-for-generic-parkinsons-disease-treatment-tablets/articleshow/127977816.cms

    ECONOMICTIMES
    06 Feb 2026
    Share Share
    Alembic’s Generics Carbidopa, Levodopa Receives Approval in US
    Alembic’s Generics Carbidopa, Levodopa Receives Approval in US

    05 Feb 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218535

    FDA
    05 Feb 2026
    Share Share
    Rising's Generic Carbidopa, Levodopa & Entacapone Receives Approval in the U.S.
    Rising's Generic Carbidopa, Levodopa & Entacapone Receives Approval in the U.S.

    25 Jan 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213212

    FDA
    25 Jan 2022
    Share Share
    Alembic Pharm's Generic Entacapone Receives Approval in the U.S.
    Alembic Pharm's Generic Entacapone Receives Approval in the U.S.

    04 Jan 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212601

    FDA
    04 Jan 2022
    Share Share
    Neurocrine Biosciences Presents Data Demonstrating Efficacy of Approved ONGENTYS
    Neurocrine Biosciences Presents Data Demonstrating Efficacy of Approved ONGENTYS

    11 Sep 2020

    // PRNNEWSWIRE

    https://www.prnewswire.com/news-releases/neurocrine-biosciences-presents-new-data-analyses-demonstrating-efficacy-of-fda-approved-once-daily-ongentys-opicapone-in-patients-with-parkinsons-disease-at-the-mds-virtual-congress-2020-301128393.html

    PRNNEWSWIRE
    11 Sep 2020
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.